Free tool
Stocks listed on NYSE
We cover 94 companies listed on NYSE. The median market value in the group is $13.82B. Across the group, the median move over the past trading day is −0.08%. 82% of the 93 with a 200-day average trade above it. Price change over the past year runs from −16.3% to +85.9% across the middle 80 percent of the group, with a median of +21.1%.
Other lists in this group
Table
94 of 1,978 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| GSK | GSK plc | $104.29B | Large cap | +32.23% |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −16.58% |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% |
| GMED | Globus Medical, Inc. | $11.16B | Large cap | +35.10% |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| ACH | Accendra Health, Inc. | $93.82M | Micro cap | −75.05% |
| ANVS | Annovis Bio, Inc. | $75.84M | Micro cap | −24.26% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.